Stocks
Reviva Pharmaceuticals Holdings, Inc.RVPH
OQBHealthcareBiotechnology$0.43
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company focused on developing therapies for central nervous system and inflammatory diseases. Its lead candidate, brilaroxazine, is in late-stage trials for schizophrenia and other neuropsychiatric disorders. Investors track RVPH for its potential in a large, underserved market and upcoming regulatory milestones.
52W Range: $0.26-$15.40
Congressional Interest in Reviva Pharmaceuticals Holdings, Inc. (RVPH)
No congressional trades have been disclosed for Reviva Pharmaceuticals Holdings, Inc. (RVPH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading RVPH?
No congressional trades found for this stock.